169 engineering-computation "https:" "https:" "https:" "https:" "https:" "https:" "https:" "UCL" positions at Leibniz in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Programme for Women Professors Leibniz Collaborative Excellence Leibniz Transfer funding programme Selection process Funded Projects Open science OPEN SCIENCE Open Access Open and FAIR Data Citizen Science
-
and technologies. The institute employs an average of 500 people from over 40 nations and, in addition to its scientific tasks, is dedicated to promoting young scientists and engineers. The IFW supports
-
The Bernhard Nocht Institute for Tropical Medicine (https://www.bnitm.de/en ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
/biomedical engineering or of relevant scientific field A solid background in machine learning Extensive experience with either computer vision or image analysis Good knowledge of deep learning packages
-
The Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB) is a pioneer and a driver of bioeconomy research. We create the scientific foundation to transform agricultural, food
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
The Bernhard Nocht Institute for Tropical Medicine (https://www.bnitm.de/en/ ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu/ ) formerly RCI – is a biomedical research center focusing on translational immunology in the fields
-
CANCER (F/M/D) Starting on May 1st, 2026 (with flexibility). We have pioneered the development of synthetic tumor immune microenvironments, engineered from artificial cells that mimic immune functions